Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick K Kamanu

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Physiological Genomics|June 19, 2016
Interactions between the colonic transcriptome, metabolome, and microbiome in mouse models of obesity-induced intestinal cancerAnna C Pfalzer, Frederick K Kamanu, Laurence D Parnell, et al.
PLOS Digital Health|February 22, 2023
Privacy-aware multi-institutional time-to-event studiesJulian Späth, Julian Matschinske, Frederick K Kamanu, et al.
Diabetes, Obesity & Metabolism|December 19, 2024
Type 2 diabetes genetic risk and incident diabetes across diabetes risk enhancersFilipe A Moura, Frederick K Kamanu, Stephen D Wiviott, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 7, 2018
Incremental Elevations in TNFα and IL6 in the Human Colon and Procancerous Changes in the Mucosal Transcriptome Accompany AdiposityAnna C Pfalzer, Keith Leung, Jimmy W Crott, et al.
Nature Medicine|June 8, 2026
Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variantsNicholas A Marston, Shinwan Kany, Giorgio E M Melloni, et al.
Circulation|November 12, 2019
Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER TrialNicholas A Marston, Frederick K Kamanu, Francesco Nordio, et al.
Nature Medicine|February 26, 2025
Endothelial cell-related genetic variants identify LDL cholesterol-sensitive individuals who derive greater benefit from aggressive lipid loweringNicholas A Marston, Frederick K Kamanu, Giorgio E M Melloni, et al.
JAMA Cardiology|December 28, 2022
Predictive Utility of a Coronary Artery Disease Polygenic Risk Score in Primary PreventionNicholas A Marston, James P Pirruccello, Giorgio E M Melloni, et al.
European Journal of Preventive Cardiology|October 28, 2025
Polygenic Risk Score for Coronary Artery Disease Across the Spectrum of Atherosclerotic DiseaseAndre Zimerman, Frederick K Kamanu, Giorgio E M Melloni, et al.
European Heart Journal|November 28, 2025
A polygenic risk score for peripheral artery disease and major adverse limb eventsSamer Al Said, Siddharth M Patel, Giorgio E M Melloni, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Physiological Genomics|June 19, 2016
Interactions between the colonic transcriptome, metabolome, and microbiome in mouse models of obesity-induced intestinal cancerAnna C Pfalzer, Frederick K Kamanu, Laurence D Parnell, et al.
PLOS Digital Health|February 22, 2023
Privacy-aware multi-institutional time-to-event studiesJulian Späth, Julian Matschinske, Frederick K Kamanu, et al.
Diabetes, Obesity & Metabolism|December 19, 2024
Type 2 diabetes genetic risk and incident diabetes across diabetes risk enhancersFilipe A Moura, Frederick K Kamanu, Stephen D Wiviott, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 7, 2018
Incremental Elevations in TNFα and IL6 in the Human Colon and Procancerous Changes in the Mucosal Transcriptome Accompany AdiposityAnna C Pfalzer, Keith Leung, Jimmy W Crott, et al.
Nature Medicine|June 8, 2026
Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variantsNicholas A Marston, Shinwan Kany, Giorgio E M Melloni, et al.
Circulation|November 12, 2019
Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER TrialNicholas A Marston, Frederick K Kamanu, Francesco Nordio, et al.
Nature Medicine|February 26, 2025
Endothelial cell-related genetic variants identify LDL cholesterol-sensitive individuals who derive greater benefit from aggressive lipid loweringNicholas A Marston, Frederick K Kamanu, Giorgio E M Melloni, et al.
JAMA Cardiology|December 28, 2022
Predictive Utility of a Coronary Artery Disease Polygenic Risk Score in Primary PreventionNicholas A Marston, James P Pirruccello, Giorgio E M Melloni, et al.
European Journal of Preventive Cardiology|October 28, 2025
Polygenic Risk Score for Coronary Artery Disease Across the Spectrum of Atherosclerotic DiseaseAndre Zimerman, Frederick K Kamanu, Giorgio E M Melloni, et al.
European Heart Journal|November 28, 2025
A polygenic risk score for peripheral artery disease and major adverse limb eventsSamer Al Said, Siddharth M Patel, Giorgio E M Melloni, et al.
Pageof 3